Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
1. 系统已在2025-11-12 15:37:53对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2468-1253(22)00427-7
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2468125322004277
其他信息:
出版社: Elsevier BV
作者: Brian G Feagan; Bruce E Sands; William J Sandborn; Matthew Germinaro; Marion Vetter; Jie Shao; Shihong Sheng; Jewel Johanns; Julián Panés; Alexander Tkachev; Dilara Kalimullina; Robert Petryka; Marina Osipenko; Nataliia Tsarynna; Leonid Bilianskyi; Dariusz Kleczkowski; Andrii Yurkiv; Marek Woynarowski; Orest Abrahamovych; Olha Ivanishyn; Grazyna Rydzewska; Jaroslaw Kierkus; Elina Petrova; Olga Vasilevskaya; Halyna Afanasieva; Carlos Francesconi; Jaroslaw Leszczyszyn; Elena Bunkova; Dmitry Platonov; Olena Datsenko; Oleksii Gridnyev; Ihor Hospodarsky; Liudmyla Prystupa; Mykola Stanislavchuk; Anatoly Pershko; Oksana Shchukina; Vladimir Simanenkov; Oleksandr Golovchenko; William Holderman; Juan Lasa; Jakob Begun; Maria de Lourdes de Abreu Ferrari; Pedro Lopez; Andrey Obrezan; Shiraz Farooq; Felix Tiongco; Abel Novillo; Emiliano Tron; Finlay Macrae; Rupert Leong; Ligia Yukie Sassaki; Cyrla Zaltman; Roberto Kaiser Junior; Andreas Stallmach; Jochen Klaus; Manuel Martinez; Azalia Ruiz; Rustem Abdulkhakov; Vishvinder Sharma; Louis Korman; James Lord; Bhaktasharan Patel; Timothy Ritter
